Publication Name	World Journal of Diabetes
Manuscript ID	90054
Country	United States

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Cohort Study
Article Title	Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study
Manuscript Source	Unsolicited Manuscript
All Author List	Joseph Matthew Gosnell, George Golovko, Esteban Arroyave, Akshata Moghe, Michael L Kueht, Omar Abdul Saldarriaga, Kevin H McKinney, Heather L Stevenson and Monique R Ferguson
Funding Agency and Grant Number	Funding Agency Grant Number Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award from the National Center for Advancing Translational Sciences at the National Institutes of Health UL1TR001439 Moody Endowment Grant 2014-07
Corresponding Author	Joseph Matthew Gosnell, MD, MS, Doctor, Doctor, Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, United States. jogosnel@utmb.edu
Key Words	Metabolic dysfunction-associated steatotic liver disease; Metabolic dysfunction-associated steatohepatitis; Hispanic; Diabetes mellitus; TriNetX; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Outcomes
Core Tip	We reviewed the outcome data between Hispanic and non-Hispanic patients diagnosed with metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis in both University of Texas Medical Branch (UTMB) and separately in a United States national cohort to determine if disparities in outcome were confined to a geographically-defined region, i.e., Southeast Texas, or observed nationally. Outcomes studied included rates of all-cause mortality, hepatocellular carcinoma, type 2 diabetes mellitus, and liver fibrosis/cirrhosis between the Hispanic and non-Hispanic. Outcome disparities between Hispanic and non-Hispanic groups were observed in the UTMB and United States cohorts at similar rates in all outcomes with the exception of all-cause mortality in the UTMB cohort.
Citation	Gosnell JM, Golovko G, Arroyave E, Moghe A, Kueht ML, Saldarriaga OA, McKinney KH, Stevenson HL, Ferguson MR. Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study. World J Diabetes 2024; 15(5): 886-897

Received	2023-12-12 22:46
Peer-Review Started	2023-12-12 22:46
To Make the First Decision
Return for Revision	2023-12-27 04:59
Revised	2024-01-09 17:15
Second Decision	2024-02-25 11:33
Accepted by Journal Editor-in-Chief	2024-02-29 11:07
Accepted by Executive Editor-in-Chief	2024-03-06 06:48
Articles in Press	2024-03-06 06:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-24 09:30

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com